Health Union: Commission signs Joint Procurement contract with HIPRA for COVID-19 vaccines
HERA, the European Commission's Health Preparedness and Response Authority, has signed a joint procurement Framework Contract with the company HIPRA HUMAN HEALTH for the supply of their protein COVID-19 vaccine. 14 Member States and countries are participating in this joint procurement, under which they can purchase up to 250 million doses. As the number of cases is again on the rise in Europe, this agreement will make the HIPRA vaccine rapidly available to the participating countries, as soon as this vaccine has received a positive assessment by the European Medicines Agency.
Commissioner for Health and Food Safety, Stella Kyriakides, recently said:
“With COVID-19 infections on the rise in Europe, we need to ensure maximum preparedness as we head into the autumn and winter months. The HIPRA vaccine adds yet another option to complement our broad vaccine portfolio for our Member States and citizens. An increase in vaccination and boosting is essential over the coming months. We are working tirelessly to make sure there are vaccines available for all. This is our European Health Union in action – preparing ahead and being ready to act.”
The joint procurement contract with HIPRA complements an already broad portfolio of vaccines secured through the EU Vaccines Strategy, including the contracts already signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, Moderna, Novavax and Valneva. Some 4.2 billion doses have been secured under the EU Vaccines Strategy. This diversified vaccine portfolio will ensure Europe continues to be well prepared for COVID-19 vaccination, using vaccines that have been proven to be safe and effective. Participating countries could decide to donate the vaccines to lower and middle-income countries or to re-direct them to other European countries.
The HIPRA bivalent recombinant protein vaccine, which is currently under rolling review by the European Medicines Agency, is being developed as a booster dose in previously immunized persons 16 years and older. The HIPRA vaccine is stored at refrigerated temperature between 2 and 8ºC, facilitating storage and distribution in Europe and across the world.
The COVID-19 vaccine from HIPRA is currently under rolling review by the European Medicines Agency (EMA). If the vaccine receives a marketing authorisation participating countries will be able to purchase the vaccine through the framework contract in place.
Latest News from
Russia’s aggression against Ukraine: the EU imposes restrictive measures on Viktor and Oleksandr Yanukovych05/08/2022 13:25:00
The Council yesterday decided to impose restrictive measures on two additional individuals in response to the ongoing unjustified and unprovoked Russian military aggression against Ukraine.
State aid: Commission approves 2022-2027 regional aid map for Denmark05/08/2022 10:38:00
The European Commission has approved under EU State aid rules Denmark's map for granting regional aid from 1 January 2022 to 31 December 2027 within the framework of the revised Regional aid Guidelines (‘RAG').
Commission welcomes international condemnation of Russia for violation of aviation rules and EU sanctions05/08/2022 09:25:00
The Commission welcomes the decision by the International Civil Aviation Organization (ICAO), the UN agency responsible for regulating air transport, to call on the Russian Federation to immediately cease its infractions of international aviation rules, in order to preserve the safety and security of civil aviation.
Mergers: Commission approves D'Ieteren's acquisition of PHE, subject to conditions04/08/2022 16:33:00
The European Commission has approved, under the EU Merger Regulation, D'Ieteren's acquisition of PHE. The approval is conditional on full compliance with commitments offered by D'Ieteren.
State aid: Commission approves €2.98 billion German scheme to promote green district heating04/08/2022 15:25:00
The European Commission has approved, under EU State aid rules, a €2.98 billion German scheme to promote green district heating based on renewable energy and waste heat.
New rights to improve work-life balance in the EU have entered into application04/08/2022 14:33:00
As of tuesday (02 July 2022), all Member States must apply EU-wide rules to improve work-life balance for parents and carers adopted in 2019.
State aid: Commission approves revised commitments by Italy for Banca Monte dei Paschi di Siena04/08/2022 13:25:00
The European Commission has approved, under EU State aid rules, a set of revised commitments submitted by Italy, replacing the original commitments on the basis of which the Commission had approved a precautionary recapitalisation of Banca Monte dei Paschi di Siena (‘MPS').
State aid: Commission approves €181.5 million Latvian schemes to support companies in context of Russia's invasion of Ukraine04/08/2022 11:33:00
The European Commission has approved two Latvian schemes with a total budget of €181.5 million to support small and medium-sized enterprises (‘SMEs') and large companies across sectors in the context of Russia's invasion of Ukraine.
EU disburses €50 million of Macro-Financial Assistance to the Republic of Moldova01/08/2022 16:33:00
The European Commission, on behalf of the EU, has disbursed €50 million in macro-financial assistance (MFA) to the Republic of Moldova, of which €35 million in long-term loans on concessional terms and €15 million in grants.